Bausch Health Companies | Ativo Circulante

Current Assets Alterar Data
Amgen USD 28.03B 2.3B 2024-03
ANI Pharmaceuticals USD 540.56M 20.74M 2024-03
Aurora Cannabis CAD 406.53M 18.55M 2023-12
Bausch Health Companies USD 5.4B 200M 2024-03
Biogen USD 6.76B 103.1M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Canopy Growth CAD 371.18M 26.1M 2024-03
Catalent USD 2.52B 47M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Danaher USD 14.37B 435M 2024-03
Drreddys Laboratories INR 238.48B 20.78B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Pacira USD 543.11M 33.12M 2024-03
Perrigo USD 2.81B 26.5M 2024-03
Prestige Brands USD 375.04M 18.74M 2024-03
Supernus Pharmaceuticals USD 544.32M 51.21M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03
Zoetis USD 6.36B 16M 2024-03



Bausch Health Companies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.